About the Event
Cambrian is a drug development company built around understanding of the biological drivers of aging. Their goal is to treat and prevent today’s deadliest diseases while unlocking the secrets of longer, healthier lives.
One of their lead candidates is a daily oral medication that treats peripheral artery disease by mimicking a day’s worth of exercise. Once approved as a treatment, the drug could then be prescribed to help healthy individuals meet exercise and weight loss goals.
Join our webinar with Cambrian CEO, James Peyer, to learn more about the company’s pipeline which is built entirely around the 13 drivers of aging to help people stay healthier and live longer.